dc.contributor.author |
Pañella, Clara |
dc.contributor.author |
Moll Sánchez, Xavier |
dc.contributor.author |
Quesada, Rita |
dc.contributor.author |
Villanueva Garatachea, Alberto |
dc.contributor.author |
Iglesias, Mar |
dc.contributor.author |
Andaluz Martínez, Anna |
dc.contributor.author |
Lucía, O. |
dc.contributor.author |
Sánchez-Velázquez, Patricia |
dc.contributor.author |
Grande, L |
dc.contributor.author |
Burdío, Fernando |
dc.date |
2019 |
dc.identifier |
https://ddd.uab.cat/record/220398 |
dc.identifier |
urn:oai:ddd.uab.cat:220398 |
dc.description.abstract |
Introduction: Irreversible Electroporation (IRE) is highly dependent on the electrical conductivity of the tissue and the high conductivity of tumor tissue, which leads to a lower field than in the surrounding healthy tissue. Hypersaline Infusion (HI) through the portal vein focuses IRE on scattered liver tumors, by creating a differential conductivity between the different types of tissue. The aim of this study is to determine the effects of the HI protocol on the hepatic and histological biochemical results. Methods: Ten male Sprague Dawley rats were used for HI protocol. Blood samples were collected at pre-, immediately post-, 24-hrs, 72-hrs, 1-week and 3-weeks post-HI. All the animals were sacrificed after one-month follow-up in order to collect histological samples. Results: The mortality rate in this procedure reached 30% (3/10). Only the pH and transaminases at 24-hrs were significantly and directly linked to mortality (p=0.036 and p=0.004, respectively). The three non-surviving animals had a four-time higher AST level at 24-hrs. Natremia normalized at 24-hrs post-HI. Statistically significant differences were found in hepatic necrosis between the non-surviving (n=3) and surviving rats (n=7) (30.67 ± 10.97 vs. 2.86 ± 7.56% respectively, p=0.01). Discussion: HI through the portal system involves a significant risk of possibly lethal cytolysis and acidosis. Therefore, compensatory measures and a reduced saline overload are warranted to improve the survival rates. |
dc.format |
application/pdf |
dc.language |
eng |
dc.publisher |
|
dc.relation |
Ministerio de Ciencia e Innovación TEC2014-52383-C3-R |
dc.relation |
Clinics in Surgery ; Núm. 4 (2019) |
dc.rights |
open access |
dc.rights |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
dc.rights |
https://creativecommons.org/licenses/by/4.0/ |
dc.subject |
Electroporació |
dc.subject |
Cirurgia |
dc.title |
Hypersaline Infusion Protocol through the Portal Vein may Focus Electroporation on Tumor Tissue, but is it really Safe? Preliminary Results |
dc.type |
Article |